Validation of the Role of Levetiracetam for Newly Diagnosed GBM Patients

NCT02815410 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

73

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma Multiforme

Interventions

DRUG: levetiracetam

Sponsor

Seoul National University Hospital